2020 Q3 Form 10-Q Financial Statement
#000087401520000142 Filed on November 04, 2020
Income Statement
Concept | 2020 Q3 | 2019 Q3 |
---|---|---|
Revenue | $160.1M | $167.9M |
YoY Change | -4.64% | 15.47% |
Cost Of Revenue | $3.100M | $1.000M |
YoY Change | 210.0% | |
Gross Profit | $157.0M | $166.9M |
YoY Change | -5.93% | |
Gross Profit Margin | 98.06% | 99.41% |
Selling, General & Admin | $68.40M | $60.00M |
YoY Change | 14.0% | -12.66% |
% of Gross Profit | 43.57% | 35.95% |
Research & Development | $125.1M | $104.4M |
YoY Change | 19.83% | 9.55% |
% of Gross Profit | 79.68% | 62.55% |
Depreciation & Amortization | $3.800M | $3.200M |
YoY Change | 18.75% | -3.03% |
% of Gross Profit | 2.42% | 1.92% |
Operating Expenses | $193.5M | $164.4M |
YoY Change | 17.7% | 0.24% |
Operating Profit | -$36.50M | $2.523M |
YoY Change | -1546.69% | -113.58% |
Interest Expense | $2.428M | $1.100M |
YoY Change | 120.73% | -184.62% |
% of Operating Profit | 43.6% | |
Other Income/Expense, Net | $100.0K | -$100.0K |
YoY Change | -200.0% | |
Pretax Income | -$31.55M | $3.500M |
YoY Change | -1001.43% | -117.59% |
Income Tax | $5.064M | -$14.90M |
% Of Pretax Income | -425.71% | |
Net Earnings | -$24.47M | $26.16M |
YoY Change | -193.52% | -673.88% |
Net Earnings / Revenue | -15.28% | 15.58% |
Basic Earnings Per Share | -$0.18 | $0.19 |
Diluted Earnings Per Share | -$0.18 | $0.18 |
COMMON SHARES | ||
Basic Shares Outstanding | 139.7M | 140.6M |
Diluted Shares Outstanding | 139.7M | 143.4M |
Balance Sheet
Concept | 2020 Q3 | 2019 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $2.329B | $2.221B |
YoY Change | 4.88% | 13.36% |
Cash & Equivalents | $633.1M | $247.9M |
Short-Term Investments | $1.696B | $1.973B |
Other Short-Term Assets | $146.6M | $118.8M |
YoY Change | 23.4% | 22.35% |
Inventory | $22.20M | $19.40M |
Prepaid Expenses | ||
Receivables | $39.00M | $49.10M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $2.537B | $2.408B |
YoY Change | 5.35% | 15.82% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $181.5M | $161.7M |
YoY Change | 12.24% | 22.5% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $348.9M | $298.2M |
YoY Change | 17.0% | 2248.03% |
Total Long-Term Assets | $558.7M | $486.9M |
YoY Change | 14.75% | 188.62% |
TOTAL ASSETS | ||
Total Short-Term Assets | $2.537B | $2.408B |
Total Long-Term Assets | $558.7M | $486.9M |
Total Assets | $3.096B | $2.895B |
YoY Change | 6.93% | 28.79% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $16.20M | $13.10M |
YoY Change | 23.66% | -3.68% |
Accrued Expenses | $109.1M | $79.10M |
YoY Change | 37.93% | 5.47% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $5.800M | |
YoY Change | ||
Total Short-Term Liabilities | $244.6M | $231.8M |
YoY Change | 5.52% | -10.91% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $814.8M | $656.7M |
YoY Change | 24.07% | 5.22% |
Other Long-Term Liabilities | $429.9M | $508.6M |
YoY Change | -15.47% | -2.83% |
Total Long-Term Liabilities | $1.245B | $1.165B |
YoY Change | 6.81% | 1.55% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $244.6M | $231.8M |
Total Long-Term Liabilities | $1.245B | $1.165B |
Total Liabilities | $1.713B | $1.559B |
YoY Change | 9.87% | 1.39% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $1.383B | $1.336B |
YoY Change | ||
Total Liabilities & Shareholders Equity | $3.096B | $2.895B |
YoY Change | 6.93% | 28.79% |
Cashflow Statement
Concept | 2020 Q3 | 2019 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$24.47M | $26.16M |
YoY Change | -193.52% | -673.88% |
Depreciation, Depletion And Amortization | $3.800M | $3.200M |
YoY Change | 18.75% | -3.03% |
Cash From Operating Activities | -$10.40M | -$12.80M |
YoY Change | -18.75% | -50.77% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$11.80M | -$15.90M |
YoY Change | -25.79% | 396.88% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $113.7M | $17.30M |
YoY Change | 557.23% | -105.68% |
Cash From Investing Activities | $101.9M | $1.400M |
YoY Change | 7178.57% | -100.45% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 11.00M | -13.20M |
YoY Change | -183.33% | -262.96% |
NET CHANGE | ||
Cash From Operating Activities | -10.40M | -12.80M |
Cash From Investing Activities | 101.9M | 1.400M |
Cash From Financing Activities | 11.00M | -13.20M |
Net Change In Cash | 102.5M | -24.60M |
YoY Change | -516.67% | -92.44% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$10.40M | -$12.80M |
Capital Expenditures | -$11.80M | -$15.90M |
Free Cash Flow | $1.400M | $3.100M |
YoY Change | -54.84% | -113.6% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000874015 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-19125 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Ionis Pharmaceuticals, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
33-0336973 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2855 Gazelle Court | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Carlsbad | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92010 | ||
dei |
City Area Code
CityAreaCode
|
760 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
931-9200 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $.001 Par Value | ||
dei |
Trading Symbol
TradingSymbol
|
IONS | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2020Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
139823135 | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
9037000 | ||
ions |
Number Of Investments In Privately Held Companies That Were Revalued
NumberOfInvestmentsInPrivatelyHeldCompaniesThatWereRevalued
|
2 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
23532000 | ||
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
358000 | ||
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
0 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
14178000 | ||
ions |
Acquisition Transaction Costs Incurred But Not Yet Paid
AcquisitionTransactionCostsIncurredButNotYetPaid
|
8103000 | ||
ions |
Acquisition Transaction Costs Incurred But Not Yet Paid
AcquisitionTransactionCostsIncurredButNotYetPaid
|
0 | ||
us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
1071000 | ||
us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
0 | ||
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | ||
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
12500000 | ||
CY2019Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
26158000 | |
CY2019Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
140551000 | |
CY2019Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.19 | |
CY2019Q3 | ions |
Incremental Common Shares Attributable To Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlan
|
20000 | |
CY2019Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
26158000 | |
CY2019Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
143408000 | |
CY2019Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.18 | |
CY2020Q4 | ions |
Cash Purchase Price Of Equity Awards
CashPurchasePriceOfEquityAwards
|
18.15 | |
CY2020Q4 | ions |
Cash Purchase Price Of Equity Awards
CashPurchasePriceOfEquityAwards
|
18.15 | |
CY2020Q4 | ions |
Cash Purchase Price Of Equity Awards
CashPurchasePriceOfEquityAwards
|
18.15 |